PolTREG appoints Dan Shelly as Chief Business Development
Gdańsk, Poland – 21 February 2024 – PolTREG S.A. (Warsaw Stock Exchange: PTG), a clinical-stage biotechnology company developing cell...
Chris Maggos Douwe Miedema Piotr Trzonkowski Daniel Shelly Prescient Therapeutics Ltd University Of Cincinnati
Source: globenewswire.com